Navigation Links
ULURU Inc. to Raise $1.5 Million in Registered Direct Offering
Date:11/12/2009

ADDISON, Texas, Nov. 12 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU), a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced it has entered into definitive agreements to sell 10,714,467 shares of its common stock at a price per share of $0.14 pursuant to a registered direct offering to institutional investors, resulting in gross proceeds of approximately $1.5 million.

Investors will also receive warrants to purchase up to 5,357,233 shares of ULURU Inc.'s common stock. The warrants have an exercise price of $0.19 per share and are exercisable at any time on or after 6 months and prior to 5 year anniversary of such initial issuance date.

The closing of the offering is expected to take place subject to the satisfaction of customary closing conditions. ULURU Inc. plans to use the net proceeds from the offering for research and development and general corporate purposes.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM), acted as the exclusive placement agent for this transaction.

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and OraDisc(TM) transmucosal delivery system. For further information about ULURU Inc., please visit our website at www.ULURUinc.com. For further information about Altrazeal(TM), please visit www.Altrazeal.com.

This press release contains certain stateme
'/>"/>

SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ULURU Inc. Presents Results of First Randomized Clinical Trial for Altrazeal(TM) at the Symposium on Advanced Wound Care (SAWC) Fall Meeting in Washington D.C.
2. ULURU Inc. Reports Second Quarter 2009 Financial Results
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30, 2009 and to Provide a Business Update
4. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada
5. ULURU Inc. Announces Status of York Note Receivable
6. ULURU Inc. Reports First Quarter 2009 Financial Results
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update
8. ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
9. ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
10. ULURU Inc. (ULURU) Dealing Disclosure Requirements
11. ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... Sunnyvale, CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was ... their communities by giving to local charities and causes. ... Thanksgiving Holiday, coincides with the kickoff of the holiday ... Friday is to shopping and Cyber Monday is to ...
(Date:11/28/2014)... 2014 Now that the holiday season ... of the nation's leading cash-for-junk-cars companies, is improving their ... be more competitive and help bring a little bit ... time of year. , Along with purchasing expensive gifts ... US also deal with large travel expenses during the ...
(Date:11/28/2014)... 2014 Novatus, a leading provider ... v5.1 which provides customers with greater reporting capabilities, ... , “As we continue to evolve and grow ... functionality and improved performance in response to requests ... Novatus. “With the enhancements that we have made ...
(Date:11/28/2014)... Dr. Andrew Campbell, one of the ... expansion of Quintessa Aesthetic Center into a third location ... W307 N1497 Golf Road in Suite 200 and will ... the new Delafield location will offer a variety of ... Botox, filler injectables , micro laser peels, chemical ...
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded ... Holiday Event for those in the area that would like to ... & Glow will take place on December 11, 2014, from 6:00 ... heart of Houston at 4208 Richmond Ave. , “We want ... will come and celebrate the season with us on December 11, ...
Breaking Medicine News(10 mins):Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3
... 18, 2011 HIV-positive head and neck cancer patients ... toxicity rates as non-HIV-positive patients, despite prior reports to ... issue of the International Journal of Radiation OncologyBiologyPhysics ... Radiation Oncology (ASTRO). , Patients with HIV have a ...
... A new program designed to create comprehensive, integrated, whole-person ... a $3.9 million grant from the Colorado Health Foundation. ... in the Department of Family Medicine at the University of ... and national leaders from the mental health, substance use, and ...
... (HealthDay News) -- Seeing a character in a movie light ... motions, new research shows. In the study, functional MRI ... 17 nonsmokers as they watched movie scenes that featured smoking. ... activity in areas involved in movement of the hand they ...
... more likely to have seriously considered suicide than their peers ... Toronto , In a paper published online this week in ... differences among a sample of 6,647 adults, of whom 695 ... study found that men from divorced families had more than ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... from patients suggest that a controversial treatment for multiple ... many physicians remain highly skeptical of the claims. ... Zamboni, a vascular surgeon from Italy, published an intriguing ...
... of Technology indicates that the incidence of maltreatment, including ... 25 percent higher among deaf and hard-of-hearing children than ... correlation between childhood maltreatment and higher rates of negative ... study, which was presented at the 2010 annual meeting ...
Cached Medicine News:Health News:HIV-positive head and neck cancer patients benefit from radiation therapy 2Health News:New program targeting whole-person health care gets major grant 2Health News:Smoking Scenes in Movies Light Up Smokers' Brains 2Health News:Parental divorce linked to suicidal thoughts 2Health News:Vein-Opening Treatment for MS Stirs Controversy 2Health News:Vein-Opening Treatment for MS Stirs Controversy 3Health News:Vein-Opening Treatment for MS Stirs Controversy 4Health News:Study: Abuse rates higher among deaf and hard-of-hearing children compared with hearing youths 2
(Date:11/27/2014)... 27, 2014 Hovione announced today ... Application with the U.S. Food and Drug Administration (FDA). ... developing improved drug delivery options for established drugs. ... novel formulation using a new patented crystalline base form ... widely prescribed oral antibiotics for acne. Currently, there are ...
(Date:11/26/2014)... Mass. , Nov. 26, 2014   ... AEX: PHIA) today announced expanded availability of its ... DuraDiagnost, DigitalDiagnost, MobileDiagnost wDR, MobileDiagnost Opta[i] , ProGrade ... these solutions now available in the U.S., and ... markets, the portfolio offers Philips, customers innovative solutions ...
(Date:11/26/2014)...  Cohen, Placitella & Roth, PC is investigating ... Nymox Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 31, 2011 through November 2, 2014 ("Class Period").  ... its officers and directors publically disseminated materially false ... and 20(a) of the Securities Exchange Act of ...
Breaking Medicine Technology:Hovione Files its First Investigational New Drug Application With the FDA 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3
... , ... event is to use an ... environment. But will the device be durable enough? Can you depend, ... its signal quality? Will the battery last? Is it comfortable, ...
... new features and state-of-the ... innovation, the SuperStim brain ... stimulation up to 30 ... and transcranial stimulation up ...
... high-volume analyzer that builds upon the field-proven ... and the latest Olympus technological advances. The ... with up to 147 on-board chemistries and ... Choose from Olympus 122 test menu, including ...
... The AU640 e is ... mid-sized to large laboratories and hospitals. ... the AU640es field-proven reliability and Olympus ... chemistries, urine chemistry, specific proteins, esoteric ...
Medicine Products: